HealthBanks Biotech

HealthBanks Group offers services to families worldwide through HealthBanks Biotech (USA) and its sister companies located in the United States, and around the world. Since its establishment in 2001, HealthBanks has become one of the most established stem cell banking network, having close to 20 years of operational experience, over 110,000 public and private clients, and most international accreditations including FACT, AABB, HOKLAS, CAP, and ISO. The establishment of HealthBanks network was the result of the vision that stem cells and other cell & gene therapies could one day transform modern medicine, and for the past 20 years, the company has grown to be one of the world’s leading private and public cell banking organization. HealthBanks Group strives for advancements in stem cell research and cell & gene therapies. In 2008, HealthBanks became the first company to offer families cord tissue storage in the world and remains a pioneer in developing applications of stem cell derived from various cord and placenta tissues. In 2019, HealthBanks became the first company to offer immune cell storage for future immunotherapies to treat cancers. In addition, the company has been at the forefront of stem cell research, vaccine development, and pharmaceuticals for nearly 20 years to identify better treatments for clinical diseases. From processing and storing cord blood in private and public banks, to discovering new ways stem cells can be used to treat and cure diseases, HealthBanks takes pride in being a leader and innovator in the cord blood and cell banking industry. With global best practices, HealthBanks is fulfilling its vision – to ensure the future benefit of cell and gene therapies to everyone in need. To learn more about HealthBanks, visit us at https://www.healthbanks.us